• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Macrocyclic Mechanism-Based Inhibitor for Neuraminidases

tetano

Editor, Senior Moderator
Chemistry. 2012 Dec 11. doi: 10.1002/chem.201200859. [Epub ahead of print]
Macrocyclic Mechanism-Based Inhibitor for Neuraminidases.
Kai H, Hinou H, Naruchi K, Matsushita T, Nishimura SI.
Source

Graduate School of Life Science and Faculty of Advanced Life Science, Hokkaido University, N21, W11, Kita-ku, Sapporo 001-0021 (Japan), Fax: (+81) 11-707-9042.
Abstract

A macrocyclic mechanism-based inhibitor for neuraminidases (NAs) bearing a 2-difluoromethylphenyl aglycone and a linker between the aglycone and C-9 positions of sialic acid was synthesized and evaluated. The macrocyclic structure was designed to keep the aglycone moiety in the active site of the neuraminidase after cleavage of the glycoside bond. When Vibrio chorelae neuraminidase (VCNA) was treated with a similar acyclic derivative in the presence of detergent, the irreversible inhibition property was disabled. In contrast, this macrocyclic compound acted as an irreversible inhibitor for VCNA in the presence of detergent. Inhibition assay for various NAs using this macrocyclic compound revealed that the irreversible inhibition property depends on the k(cat) of the neuraminidase treated. NAs having small k(cat) values, such as Influenza viruses, Clostridium, Trypanosoma cruzi, and Human, were also inhibited irreversibly. However, Salmonella typhimurium NA, which has an extremely high k(cat) , was not affected irreversibly by the inhibitor. Interestingly, in contrast to common k(cat) inhibitors, the irreversibility of inhibition by this macrocyclic compound is inversely proportional to the k(cat) of the target neuraminidase.

Copyright ? 2012 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

PMID:
23233350
[PubMed - as supplied by publisher]

http://www.ncbi.nlm.nih.gov/pubmed/23233350
 
Back
Top Bottom